Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects

被引:169
作者
Arya, Jaya [1 ]
Henry, Sebastien [1 ]
Kalluri, Haripriya [1 ]
McAllister, Devin V. [1 ]
Pewin, Winston P. [1 ]
Prausnitz, Mark R. [1 ]
机构
[1] Georgia Inst Technol, Atlanta, GA 30332 USA
基金
美国国家卫生研究院;
关键词
Dissolvable microneedle patch; Human study; Skin vaccination; Acceptability; Usability; Tolerability; Drug delivery; VACCINE DELIVERY; INFLUENZA VACCINATION; CLINICAL-PRACTICE; DRUG; SKIN; TECHNOLOGY; OPINIONS; SUCCESS; PAIN;
D O I
10.1016/j.biomaterials.2017.02.040
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To support translation of microneedle patches from pre-clinical development into clinical trials, this study examined the effect of microneedle patch application on local skin reactions, reliability of use and acceptability to patients. Placebo patches containing dissolving microneedles were administered to fifteen human participants. Microneedle patches were well tolerated in the skin with no pain or swelling and only mild erythema localized to the site of patch administration that resolved fully within seven days. Microneedle patches could be administered by hand without the need of an applicator and delivery efficiencies were similar for investigator-administration and self-administration. Microneedle patch administration was not considered painful and the large majority of subjects were somewhat or fully confident that they self-administered patches correctly. Microneedle patches were overwhelmingly preferred over conventional needle and syringe injection. Altogether, these results demonstrate that dissolving microneedle patches were well tolerated, easily usable and strongly accepted by human subjects, which will facilitate further clinical translation of this technology. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 20 条
  • [1] Arya J., J CONTROLLED RELEASE
  • [2] Microneedles in Clinical Practice-An Exploratory Study Into the Opinions of Healthcare Professionals and the Public
    Birchall, James C.
    Clemo, Rachel
    Anstey, Alexander
    John, Dai N.
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (01) : 95 - 106
  • [3] Transdermal Drug Delivery Mediated by Microneedle Arrays: Innovations and Barriers to Success
    Caffarel-Salvador, Ester
    Donnelly, Ryan F.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) : 1105 - 1117
  • [4] Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis
    Daddona, Peter E.
    Matriano, James. A.
    Mandema, Jaap
    Maa, Yuh-Fun
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (01) : 159 - 165
  • [5] FDA, 2016, GUID IND TOX GRAD SC
  • [6] FDA, 2016, GUID IND SKIN IRR SE
  • [7] Effect of microneedle design on pain in human volunteers
    Gill, Harvinder S.
    Denson, Donald D.
    Burris, Brett A.
    Prausnitz, Mark R.
    [J]. CLINICAL JOURNAL OF PAIN, 2008, 24 (07) : 585 - 594
  • [8] Clinical administration of microneedles: skin puncture, pain and sensation
    Haq, M. I.
    Smith, E.
    John, D. N.
    Kalavala, M.
    Edwards, C.
    Anstey, A.
    Morrissey, A.
    Birchall, J. C.
    [J]. BIOMEDICAL MICRODEVICES, 2009, 11 (01) : 35 - 47
  • [9] Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch
    Hirobe, Sachiko
    Azukizawa, Hiroaki
    Hanafusa, Takaaki
    Matsuo, Kazuhiko
    Quan, Ying-Shu
    Kamiyama, Fumio
    Katayama, Ichiro
    Okada, Naoki
    Nakagawa, Shinsaku
    [J]. BIOMATERIALS, 2015, 57 : 50 - 58
  • [10] Microneedles for drug and vaccine delivery
    Kim, Yeu-Chun
    Park, Jung-Hwan
    Prausnitz, Mark R.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (14) : 1547 - 1568